/Holly Archer

About Holly Archer

This author has not yet filled in any details.
So far Holly Archer has created 13 blog entries.

US FDA Grants Once Daily Dosing Option For NITYR (nitisinone) Tablets for HT-1 Patients

By | September 14th, 2020|Generics, News|

Dr David Buckeridge Joins Cycle Pharmaceuticals’ Board of Directors

By | September 8th, 2020|Generics, News|

Cycle Pharmaceuticals Features in the Sunday Times Tech Track Ones to Watch 2020

By | September 8th, 2020|Generics, News|

Cycle Launches COVID-19 Response For Eligible Patients with Tyrosinemia Type 1 (HT-1)

By | August 5th, 2020|News, Nityr|

Cycle Pharmaceuticals’ NITYR® (nitisinone) Tablets Receives Marketing Authorization in the Kingdom of Saudi Arabia

By | May 13th, 2020|News, Nityr|

Cycle Pharmaceuticals and Medherant Partner to Develop Medicines using the TEPI Patch® Technology

By | May 5th, 2020|News, Nityr|

Cycle Pharmaceuticals Launches New Informative Online Meeting Series for Patients With Tyrosinemia Type 1 in the US

By | April 19th, 2020|News, Resource|

Cycle Pharmaceuticals is pleased to announce that it has signed an agreement with Baylor Genetics

By | December 18th, 2019|News, Nityr|

Health Canada has approved an updated version of the NITISINONE TABLETS’ Product Monograph

By | November 18th, 2019|News, Nityr|

Cycle Pharmaceuticals and Catalent Partner to Develop Treatments for Rare Diseases using Zydis ODT Technology

By | October 31st, 2019|News, Nityr|